GlassScriptPhysician profile
Kenneth L Bryant
NPI 1821007949
$24,431.42
in general payments reported to CMS, 2019-2025
12 companies · $134 in 2025
The $134 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $14.98 · 2021: $99.42 · 2022: $15K · 2023: $9,037 · 2024: $105 · 2025: $134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,000 · Travel and Lodging: $1,261 · Food and Beverage: $998 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,000.00 |
| Travel and Lodging | $1,261.46 |
| Food and Beverage | $998.16 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $23,833.19 | 2022-2023 | Davinci Xi, Da Vinci Surgical System |
| Organogenesis INC. | $291.73 | 2021-2025 | Puraply, Cygnus Matrix |
| Glaxosmithkline, LLC. | $67.34 | 2025 | Arexvy |
| Integra Lifesciences Corporation | $38.37 | 2020-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Ethicon US, LLC | $35.77 | 2021 | |
| Molli Surgical (US) INC | $32.23 | 2023 | |
| Mimedx Group, INC. | $31.05 | 2025 | |
| Bioventus LLC | $27.22 | 2022 | |
| Reprise Biomedical, INC. | $23.07 | 2024 | Miro3d |
| Smith+Nephew, INC. | $19.74 | 2024 | Grafix Pl |
| Kerecis Limited | $17.37 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Solventum Corporation | $14.34 | 2025 | 3m Coban, Activ.A.C. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Bryant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.